Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Chen, Jun ^a   Shao, Jiasheng ^a   Cai, Rentian ^a   Shen, Yinzhong ^a   Zhang, Renfang ^a   Liu, Li ^a   Qi, Tangkai ^a   Lu, Hongzhou ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRYPTOPHAN; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CD14 ANTIGEN BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KYNURENINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; TREATMENT DURATION; TRYPTOPHAN BLOOD LEVEL; VIRUS LOAD; BLOOD; HIV INFECTIONS; METABOLISM;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIGENS, CD14; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; MALE; TRYPTOPHAN;

EID: 84903731105     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100446     Document Type: Article

References (43)

1. Mellor A (2005) Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun 338: 20-24.
2. Byrne GI, Lehmann LK, Landry GJ (1986) Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 53: 347-351. (Pubitemid 16073864)
3. Pfefferkorn ER (1984) Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A 81: 908-912.
4. Hassanain HH, Chon SY, Gupta SL (1993) Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and -alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor. J Biol Chem 268: 5077-5084. (Pubitemid 23081633)
5. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774. (Pubitemid 39336293)
6. Taylor MW, Feng GS (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5: 2516-2522. (Pubitemid 21905800)
7. Grant RS, Naif H, Thuruthyil SJ, Nasr N, Littlejohn T, et al. (2000) Induction of indoleamine 2,3-dioxygenase in primary human macrophages by HIV-1. Redox Rep 5: 105-107. (Pubitemid 30487978)
8. Manches O, Munn D, Fallahi A, Lifson J, Chaperot L, et al. (2008) HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J Clin Invest 118: 3431-3439.
9. Huengsberg M, Winer JB, Gompels M, Round R, Ross J, et al. (1998) Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem 44: 858-862. (Pubitemid 28176030)
10. Zangerle R, Widner B, Quirchmair G, Neurauter G, Sarcletti M, et al. (2002) Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Clin Immunol 104: 242-247. (Pubitemid 35191100)
11. Guillemin GJ, Wang L, Brew BJ (2005) Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J Neuroinflammation 2: 16.
12. Frick B, Schroecksnadel K, Neurauter G, Leblhuber F, Fuchs D (2004) Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem 37: 684-687. (Pubitemid 39078460)
13. Pertovaara M, Raitala A, Lehtimaki T, Karhunen PJ, Oja SS, et al. (2006) Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Ageing Dev 127: 497-499.
14. Byakwaga H, Boum Y, 2nd, Huang Y, Muzoora C, Kembabazi A, et al. (2014) The Kynurenine Pathway of Tryptophan Catabolism, CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating ART. J Infect Dis.
15. Zhang X, He Y, Ding M (2009) Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 877: 1678-1682.
16. Nixon DE, Landay AL (2010) Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 5: 498-503.
17. Jenabian MA, Patel M, Kema I, Kanagaratham C, Radzioch D, et al. (2013) Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers. PLoS One 8: e78146.
18. Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, et al. (2007) HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109: 3351-3359. (Pubitemid 46572523)
19. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, et al. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196: 459-468.
20. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35: 702-721.
21. Davies NW, Guillemin G, Brew BJ (2010) Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder. Int J Tryptophan Res 3: 121-140.
22. Samikkannu T, Rao KV, Gandhi N, Saxena SK, Nair MP (2010) Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS. J Neurovirol 16: 255-263.
23. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J (2011) Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 32: 7-24.
24. Martinez P, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, et al. (2014) Reversal of the Kynurenine Pathway of Tryptophan Catabolism May Improve Depression in ART-Treated HIV-Infected Ugandans. J Acquir Immune Defic Syndr 65: 456-462.
25. Cassol E, Malfeld S, Mahasha P, van der Merwe S, Cassol S, et al. (2010) Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J Infect Dis 202: 723-733.
26. Kamat A, Misra V, Cassol E, Ancuta P, Yan Z, et al. (2012) A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS One 7: e30881.
27. Sandler NG, Douek DC (2012) Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 10: 655-666.
28. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203: 780-790.
29. Karris MY, Kao YT, Patel D, Dawson M, Woods SP, et al. (2014) Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection. AIDS 28: 841-849.
30. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, et al. (2010) Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2: 32ra36.
31. Loughman JA, Hunstad DA (2012) Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J Infect Dis 205: 1830-1839.
32. Leonhardt RM, Lee SJ, Kavathas PB, Cresswell P (2007) Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis. Infect Immun 75: 5105-5117. (Pubitemid 350033597)
33. Wirthgen E, Tuchscherer M, Otten W, Domanska G, Wollenhaupt K, et al. (2014) Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model. Innate Immun 20: 30-39.
34. Dinel AL, Andre C, Aubert A, Ferreira G, Laye S, et al. (2014) Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome. Psychoneuroendocrinology 40: 48-59.
35. Hattab S, Guihot A, Guiguet M, Fourati S, Carcelain G, et al. (2014) Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study. BMC Infect Dis 14: 122.
36. Mendez-Lagares G, Romero-Sanchez MC, Ruiz-Mateos E, Genebat M, Ferrando-Martinez S, et al. (2013) Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14. J Infect Dis 207: 1221-1225.
37. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, et al. (2013) Dysbiosis of the gut microbiota is associated with hiv disease progression and tryptophan catabolism. Sci Transl Med 5: 193ra191.
38. Boasso A, Vaccari M, Hryniewicz A, Fuchs D, Nacsa J, et al. (2007) Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. J Virol 81: 11593-11603. (Pubitemid 47623791)
39. Favre D, Lederer S, Kanwar B, Ma ZM, Proll S, et al. (2009) Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 5: e1000295.
40. Planes R, Bahraoui E (2013) HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation. PLoS One 8: e74551.
41. Thackray SJ, Mowat CG, Chapman SK (2008) Exploring the mechanism of tryptophan 2,3-dioxygenase. Biochem Soc Trans 36: 1120-1123.
42. Le Floc'h N, Otten W, Merlot E (2011) Tryptophan metabolism, from nutrition to potential therapeutic applications. Amino Acids 41: 1195-1205.
43. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, et al. (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478: 197-203.